Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinocerebellar Ataxia Type 3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04714307
What this trial is testing

Neuropsychiatry and Cognition in SCA3/MJD

Who this might be right for
Spinocerebellar Ataxia Type 3Machado-Joseph DiseaseSCA3+1 more
Hospital de Clinicas de Porto Alegre 144
Not applicableUnknownNCT04419974
What this trial is testing

Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes

Who this might be right for
Spinocerebellar Ataxia Type 3Machado-Joseph DiseaseSCA3+1 more
Hospital de Clinicas de Porto Alegre 95
Not applicableStudy completedNCT01811706
What this trial is testing

Dalfampridine and Gait in Spinocerebellar Ataxias

Who this might be right for
Spinocerebellar Ataxias Type 1Spinocerebellar Ataxias Type 2Spinocerebellar Ataxias Type 3+1 more
University of Florida 20
Testing effectiveness (Phase 2)Study completedNCT00992771
What this trial is testing

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

Who this might be right for
Spinocerebellar Ataxia Type 3
University of South Florida 20
Not applicableStudy completedNCT03120013
What this trial is testing

Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia

Who this might be right for
Ataxia, CerebellarCerebellar AtaxiaSpinocerebellar Ataxias+8 more
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 21
Not applicableStudy completedNCT03087526
What this trial is testing

NIPD on CFTC for Triplet Repeat Diseases

Who this might be right for
Non Invasive Prenatal Diagnosis
University Hospital, Montpellier 60
Large-scale testing (Phase 3)Study completedNCT02960893
What this trial is testing

Trial in Adult Participants With Spinocerebellar Ataxia (SCA)

Who this might be right for
Spinocerebellar AtaxiasSpinocerebellar Ataxia Genotype Type 1Spinocerebellar Ataxia Genotype Type 2+5 more
Biohaven Pharmaceuticals, Inc. 141
Testing effectiveness (Phase 2)WithdrawnNCT04301284
What this trial is testing

Study of CAD-1883 for Spinocerebellar Ataxia

Who this might be right for
Spinocerebellar AtaxiasSpinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2+7 more
Cadent Therapeutics
Not applicableStudy completedNCT04268147
What this trial is testing

Instrumented Data Exchange for Ataxia Study

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia Type 3+2 more
University of Chicago 128
Not applicableUnknownNCT03487367
What this trial is testing

Clinical Trial Readiness for SCA1 and SCA3

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia 3
The Methodist Hospital Research Institute 200
Not applicableUnknownNCT02175290
What this trial is testing

Machado-Joseph Disease in Israel

Who this might be right for
Spinocerebellar Ataxia 3
Meir Medical Center 250
Not applicableStudy completedNCT00654251
What this trial is testing

Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias

Who this might be right for
Spinocerebellar Ataxia
University of Mississippi Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT05038306
What this trial is testing

Chinese Medicine WT for Spinocerebellar Ataxia Type 3

Who this might be right for
Ataxia, SpinocerebellarInsulin-Like Growth Factor IMedicine, Chinese Traditional
Changhua Christian Hospital 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03378414
What this trial is testing

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia Type 3+1 more
Sclnow Biotechnology Co., Ltd. 45
Testing effectiveness (Phase 2)Looking for participantsNCT05822908
What this trial is testing

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 3Huntington Disease
Vico Therapeutics B. V. 68
Not applicableStudy completedNCT01037777
What this trial is testing

RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7

Who this might be right for
Spinocerebellar Ataxias
Institut National de la Santé Et de la Recherche Médicale, France 37
Not applicableStudy completedNCT01470729
What this trial is testing

Biomarkers in Autosomal Dominant Cerebellar Ataxia

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia, Autosomal Recessive 3+1 more
Assistance Publique - Hôpitaux de Paris 102
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Next Page